Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Temporal complexity of repolarization and mortality in patients with implantable cardioverter defibrillators.

Perkiomaki JS, Couderc JP, Daubert JP, Zareba W.

Pacing Clin Electrophysiol. 2003 Oct;26(10):1931-6.

PMID:
14516331
2.

Fractal correlation properties of heart rate dynamics and adverse events in patients with implantable cardioverter-defibrillators.

Perkiömäki JS, Zareba W, Daubert JP, Couderc JP, Corsello A, Kremer K.

Am J Cardiol. 2001 Jul 1;88(1):17-22.

PMID:
11423052
3.

Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device.

Ambardekar AV, Allen LA, Lindenfeld J, Lowery CM, Cannon AP, Cleveland JC Jr, Brieke A, Sauer WH.

J Heart Lung Transplant. 2010 Jul;29(7):771-6. doi: 10.1016/j.healun.2010.02.001. Epub 2010 Mar 29.

PMID:
20347337
4.

Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.

Salerno-Uriarte JA, De Ferrari GM, Klersy C, Pedretti RF, Tritto M, Sallusti L, Libero L, Pettinati G, Molon G, Curnis A, Occhetta E, Morandi F, Ferrero P, Accardi F; ALPHA Study Group Investigators.

J Am Coll Cardiol. 2007 Nov 6;50(19):1896-904. Epub 2007 Oct 22.

5.

Effectiveness of implantable cardioverter-defibrillators in patients with ischemic heart disease and left ventricular dysfunction.

Chan PS, Chow T, Kereiakes D, Schloss EJ, Waller T, Eagle K, Hayward RA, Vijan S.

Arch Intern Med. 2006 Nov 13;166(20):2228-33.

PMID:
17101941
6.

Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.

Whang W, Mittleman MA, Rich DQ, Wang PJ, Ruskin JN, Tofler GH, Muller JE, Albert CM; TOVA Investigators.

Circulation. 2004 Mar 23;109(11):1386-91. Epub 2004 Mar 1.

7.

Ventricular proarrhythmic effects of atrial fibrillation are modulated by depolarization and repolarization anomalies in patients with left ventricular dysfunction.

Lemola K, Khan R, Nattel S, Talajic M, Roy D, Guerra PG, Lemola S, Dubuc M, Thibault B, Macle L, Khairy P.

Pacing Clin Electrophysiol. 2009 Jan;32(1):99-105. doi: 10.1111/j.1540-8159.2009.02182.x.

PMID:
19140919
8.

Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.

Ladwig KH, Baumert J, Marten-Mittag B, Kolb C, Zrenner B, Schmitt C.

Arch Gen Psychiatry. 2008 Nov;65(11):1324-30. doi: 10.1001/archpsyc.65.11.1324.

PMID:
18981344
9.

Predictors of appropriate implantable cardioverter-defibrillator therapy during long-term follow-up of patients with coronary artery disease.

Blumer J, Wolber T, Hellermann J, Holzmeister J, Binggeli C, Duru F, Brunckhorst C.

Int Heart J. 2009 May;50(3):313-21.

10.

Influence of the vectorcardiogram synthesis matrix on the power of the electrocardiogram-derived spatial QRS-T angle to predict arrhythmias in patients with ischemic heart disease and systolic left ventricular dysfunction.

Man S, Algra AM, Schreurs CA, Borleffs CJ, Scherptong RW, van Erven L, van der Wall EE, Cannegieter SC, Schalij MJ, Swenne CA.

J Electrocardiol. 2011 Jul-Aug;44(4):410-5. doi: 10.1016/j.jelectrocard.2011.04.007.

PMID:
21704219
11.

Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.

Roes SD, Borleffs CJ, van der Geest RJ, Westenberg JJ, Marsan NA, Kaandorp TA, Reiber JH, Zeppenfeld K, Lamb HJ, de Roos A, Schalij MJ, Bax JJ.

Circ Cardiovasc Imaging. 2009 May;2(3):183-90. doi: 10.1161/CIRCIMAGING.108.826529. Epub 2009 Mar 23.

12.

Predicting ventricular arrhythmias in patients with ischemic heart disease: clinical application of the ECG-derived QRS-T angle.

Borleffs CJ, Scherptong RW, Man SC, van Welsenes GH, Bax JJ, van Erven L, Swenne CA, Schalij MJ.

Circ Arrhythm Electrophysiol. 2009 Oct;2(5):548-54. doi: 10.1161/CIRCEP.109.859108. Epub 2009 Aug 5.

13.

Prediction of ventricular tachyarrhythmias by intracardiac repolarization variability analysis.

Tereshchenko LG, Fetics BJ, Domitrovich PP, Lindsay BD, Berger RD.

Circ Arrhythm Electrophysiol. 2009 Jun;2(3):276-84. doi: 10.1161/CIRCEP.108.829440. Epub 2009 Mar 6.

14.

Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.

Rienstra M, Smit MD, Nieuwland W, Tan ES, Wiesfeld AC, Anthonio RL, Van den Berg MP, Van Veldhuisen DJ, Van Gelder IC.

Am Heart J. 2007 Jan;153(1):120-6.

PMID:
17174649
15.

Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis.

Aizer A, Stern EH, Gomes JA, Teirstein AS, Eckart RE, Mehta D.

Am J Cardiol. 2005 Jul 15;96(2):276-82.

PMID:
16018857
16.

Mortality rates and clinical predictors of reduced survival after cardioverter defibrillator implantation.

Thibodeau JB, Pillarisetti J, Khumri TM, Jones PG, Main ML.

Am J Cardiol. 2008 Mar 15;101(6):861-4. doi: 10.1016/j.amjcard.2007.10.048. Epub 2008 Feb 21.

PMID:
18328854
17.

QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.

Haigney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, McNitt S, Andrews ML, Moss AJ; Multicenter Automatic Defibrillator Implantation Trial II investigators.

J Am Coll Cardiol. 2004 Oct 6;44(7):1481-7.

18.

Atrial fibrillation predicts appropriate shocks in primary prevention implantable cardioverter-defibrillator patients.

Smit MD, Van Dessel PF, Rienstra M, Nieuwland W, Wiesfeld AC, Tan ES, Anthonio RL, Van Veldhuisen DJ, Van Gelder IC.

Europace. 2006 Aug;8(8):566-72.

PMID:
16864611
19.

Early EPS/ICD strategy in survivors of acute myocardial infarction with severe left ventricular dysfunction on optimal beta-blocker treatment. The BEta-blocker STrategy plus ICD trial.

Raviele A, Bongiorni MG, Brignole M, Cappato R, Capucci A, Gaita F, Gulizia M, Mangiameli S, Montenero AS, Pedretti RF, Uriarte JA, Sermasi S, Nisam S; BEST + ICD Trial Investigators.

Europace. 2005 Jul;7(4):327-37.

PMID:
16028343
20.

Usefulness of microvolt T-wave alternans on predicting outcome in patients with ischemic cardiomyopathy with and without defibrillators.

Chow T, Saghir S, Bartone C, Goebel M, Schneider J, Booth T, Chan PS.

Am J Cardiol. 2007 Aug 15;100(4):598-604. Epub 2007 Jun 28.

PMID:
17697813

Supplemental Content

Support Center